Evaluating the cost-effectiveness of genetic testing for pancreatic cancer
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
This study is looking at the best ways to use genetic testing for people with pancreatic cancer, focusing on how many genes to test and how it affects patients and their families emotionally, all to help improve care and reduce unnecessary procedures.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10814826 on NIH RePORTER |
What this research studies
This research investigates how to effectively implement germline genetic testing for patients diagnosed with pancreatic ductal adenocarcinoma (PDAC). It aims to identify the optimal number of genes to test and assess the emotional impact of testing on patients and their families. By developing a mathematical model, the study will simulate various testing scenarios and treatment decisions, ultimately seeking to improve patient outcomes while minimizing unnecessary procedures. Patient surveys will also be conducted to gather insights on distress related to genetic testing and communication of results.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who may benefit from genetic testing.
Not a fit: Patients with pancreatic cancer who do not have a germline genetic mutation or those who are not eligible for genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and efficient genetic testing strategies for pancreatic cancer, improving patient care and outcomes.
How similar studies have performed: Previous research has shown promising results in the cost-effectiveness of genetic testing in other cancers, suggesting potential for success in this area as well.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Peters, Mary Linton B — Beth Israel Deaconess Medical Center
- Study coordinator: Peters, Mary Linton B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.